168 related articles for article (PubMed ID: 33845027)
1. Inflammatory breast cancer: early recognition and diagnosis is critical.
Hester RH; Hortobagyi GN; Lim B
Am J Obstet Gynecol; 2021 Oct; 225(4):392-396. PubMed ID: 33845027
[TBL] [Abstract][Full Text] [Related]
2. Trimodal therapy for inflammatory breast cancer: a surgeon's perspective.
Li BD; Sicard MA; Ampil F; Abreo F; Lilien D; Chu QD; Burton GV
Oncology; 2010; 79(1-2):3-12. PubMed ID: 21051912
[TBL] [Abstract][Full Text] [Related]
3. UNICANCER-PEGASE 07 study: a randomized phase III trial evaluating postoperative docetaxel-5FU regimen after neoadjuvant dose-intense chemotherapy for treatment of inflammatory breast cancer.
Gonçalves A; Pierga JY; Ferrero JM; Mouret-Reynier MA; Bachelot T; Delva R; Fabbro M; Lerebours F; Lotz JP; Linassier C; Dohollou N; Eymard JC; Leduc B; Lemonnier J; Martin AL; Boher JM; Viens P; Roché H
Ann Oncol; 2015 Aug; 26(8):1692-7. PubMed ID: 25943350
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer subtypes can be a predictor of pathologic complete response and survival in the neoadjuvant setting for T4 noninflammatory breast cancer.
Gülben K; Berberoğlu U; Kinaş V; Başkan E
Acta Chir Belg; 2014; 114(3):153-9. PubMed ID: 25102703
[TBL] [Abstract][Full Text] [Related]
5. Delayed Diagnosis of Inflammatory Breast Cancer Presenting as Acute Mastitis in a Patient One Month Postpartum.
Seth A; Slama EM
Am Surg; 2024 Jul; 90(7):1925-1927. PubMed ID: 38523415
[TBL] [Abstract][Full Text] [Related]
6. Influence of Biologic Subtype of Inflammatory Breast Cancer on Response to Neoadjuvant Therapy and Cancer Outcomes.
Hieken TJ; Murphy BL; Boughey JC; Degnim AC; Glazebrook KN; Hoskin TL
Clin Breast Cancer; 2018 Aug; 18(4):e501-e506. PubMed ID: 29089281
[TBL] [Abstract][Full Text] [Related]
7. Current Surgical Management of Inflammatory Breast Cancer.
Adesoye T; Lucci A
Ann Surg Oncol; 2021 Oct; 28(10):5461-5467. PubMed ID: 34346020
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory breast cancer: the disease, the biology, the treatment.
Robertson FM; Bondy M; Yang W; Yamauchi H; Wiggins S; Kamrudin S; Krishnamurthy S; Le-Petross H; Bidaut L; Player AN; Barsky SH; Woodward WA; Buchholz T; Lucci A; Ueno NT; Cristofanilli M
CA Cancer J Clin; 2010; 60(6):351-75. PubMed ID: 20959401
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for locoregional failure in patients with inflammatory breast cancer treated with trimodality therapy.
Saigal K; Hurley J; Takita C; Reis IM; Zhao W; Rodgers SE; Wright JL
Clin Breast Cancer; 2013 Oct; 13(5):335-43. PubMed ID: 23850216
[TBL] [Abstract][Full Text] [Related]
10. The Impact of Residual Disease After Preoperative Systemic Therapy on Clinical Outcomes in Patients with Inflammatory Breast Cancer.
Nakhlis F; Regan MM; Warren LE; Bellon JR; Hirshfield-Bartek J; Duggan MM; Dominici LS; Golshan M; Jacene HA; Yeh ED; Mullaney EE; Overmoyer B
Ann Surg Oncol; 2017 Sep; 24(9):2563-2569. PubMed ID: 28560598
[TBL] [Abstract][Full Text] [Related]
11. Better survival after surgery of the primary tumor in stage IV inflammatory breast cancer.
van Uden DJP; van Maaren MC; Strobbe LJA; Bult P; Stam MR; van der Hoeven JJ; Siesling S; de Wilt JHW; Blanken-Peeters CFJM
Surg Oncol; 2020 Jun; 33():43-50. PubMed ID: 32561098
[TBL] [Abstract][Full Text] [Related]
12. What radiologists need to know about diagnosis and treatment of inflammatory breast cancer: a multidisciplinary approach.
Yeh ED; Jacene HA; Bellon JR; Nakhlis F; Birdwell RL; Georgian-Smith D; Giess CS; Hirshfield-Bartek J; Overmoyer B; Van den Abbeele AD
Radiographics; 2013; 33(7):2003-17. PubMed ID: 24224593
[TBL] [Abstract][Full Text] [Related]
13. Racial Differences in the Use and Outcome of Neoadjuvant Chemotherapy for Breast Cancer: Results From the National Cancer Data Base.
Killelea BK; Yang VQ; Wang SY; Hayse B; Mougalian S; Horowitz NR; Chagpar AB; Pusztai L; Lannin DR
J Clin Oncol; 2015 Dec; 33(36):4267-76. PubMed ID: 26598753
[TBL] [Abstract][Full Text] [Related]
14. Tailoring Treatment for Patients with Inflammatory Breast Cancer.
Newman AB; Lynce F
Curr Treat Options Oncol; 2023 Jun; 24(6):580-593. PubMed ID: 37043118
[TBL] [Abstract][Full Text] [Related]
15. Lessons learned from an unusual case of inflammatory breast cancer.
Harrison AM; Zendejas B; Ali SM; Scow JS; Farley DR
J Surg Educ; 2012; 69(3):350-4. PubMed ID: 22483137
[TBL] [Abstract][Full Text] [Related]
16. Recurrent granulomatous mastitis mimicking inflammatory breast cancer.
Ergin AB; Cristofanilli M; Daw H; Tahan G; Gong Y
BMJ Case Rep; 2011 Jan; 2011():. PubMed ID: 22715267
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory Breast Cancer: Is There a Role for Deescalation of Surgery?
Nakhlis F
Ann Surg Oncol; 2022 Oct; 29(10):6106-6113. PubMed ID: 35840847
[TBL] [Abstract][Full Text] [Related]
18. [Mastitis as a symptom of malignancy].
van Uden DJ; Westenberg AH; van Laarhoven HW; Meijer JW; de Wilt JH; Blanken-Peeters CF
Ned Tijdschr Geneeskd; 2014; 158():A7591. PubMed ID: 25182270
[TBL] [Abstract][Full Text] [Related]
19. Persistent disparities in breast cancer surgical outcomes among hispanic and African American patients.
Mets EJ; Chouairi FK; Gabrick KS; Avraham T; Alperovich M
Eur J Surg Oncol; 2019 Apr; 45(4):584-590. PubMed ID: 30683449
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory breast cancer: a single centre analysis.
Gogia A; Raina V; Deo SV; Shukla NK; Mohanti BK; Sharma DN
Asian Pac J Cancer Prev; 2014; 15(7):3207-10. PubMed ID: 24815472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]